{"id":155,"date":"2015-11-04T11:42:43","date_gmt":"2015-11-04T17:42:43","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=155"},"modified":"2018-09-12T16:16:10","modified_gmt":"2018-09-12T21:16:10","slug":"zofran-actions-consolidated-in-multidistrict-litigation","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/","title":{"rendered":"Zofran Actions Consolidated in Multidistrict Litigation"},"content":{"rendered":"<p>According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the use of the anti-nausea drug resulted in children being born with severe birth defects. As a result of the high number of Zofran and related drug lawsuits being brought, they have been consolidated in a multidistrict litigation, or MDL, in the District Court of Massachusetts in Boston. The United States Judicial Panel on Multidistrict Litigation has named the action <a href=\"http:\/\/www.jpml.uscourts.gov\/sites\/jpml\/files\/MDL-2657-Initial_Transfer-10-15.pdf\" target=\"_blank\">MDL No. 2657<\/a>, or\u00a0<em>In Re: Zofran (Ondansetron) Products Liability Litigation<\/em>.<\/p>\n<p>The prescription drugs Zofran, also known as\u00a0ondansetron, and Zuplenz have been associated with severe and debilitating pregnancy complications and birth defects. Doctors initially prescribed the drugs to pregnant women to help curb the high levels of vomiting and nausea that pregnant women often experience. Studies have linked the drugs to birth defects, causing families who have suffered grave consequences as a result to bring lawsuits against the maker of the drug, GlaxoSmithKline, claiming that the company marketed the drug to the public without first obtaining appropriate U.S. Food and Drug Administration (&#8220;FDA&#8221;) approvals.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/#more-155\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the use of the anti-nausea drug resulted in children being born with severe birth defects. As a result of the high number of Zofran and related drug lawsuits being brought, they have been consolidated in a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-155","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zofran Actions Consolidated in Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; November 4, 2015<\/title>\n<meta name=\"description\" content=\"According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the &#8212; November 4, 2015\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Zofran Actions Consolidated in Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; November 4, 2015\" \/>\n<meta name=\"twitter:description\" content=\"According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the &#8212; November 4, 2015\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zofran Actions Consolidated in Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; November 4, 2015","description":"According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the &#8212; November 4, 2015","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/","twitter_card":"summary_large_image","twitter_title":"Zofran Actions Consolidated in Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; November 4, 2015","twitter_description":"According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the &#8212; November 4, 2015","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Zofran Actions Consolidated in Multidistrict Litigation","datePublished":"2015-11-04T17:42:43+00:00","dateModified":"2018-09-12T21:16:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/"},"wordCount":565,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/","url":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/","name":"Zofran Actions Consolidated in Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; November 4, 2015","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2015-11-04T17:42:43+00:00","dateModified":"2018-09-12T21:16:10+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"According to nationwide reports, families are bringing countless\u00a0lawsuits against the makers of the drug Zofran and related substances, alleging\u00a0that the &#8212; November 4, 2015","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/zofran-actions-consolidated-in-multidistrict-litigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Zofran Actions Consolidated in Multidistrict Litigation"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=155"}],"version-history":[{"count":4,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/155\/revisions"}],"predecessor-version":[{"id":2345,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/155\/revisions\/2345"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}